EU
Investment Plan for Europe backs fund to support health-care innovation
The European Investment Fund (EIF) has committed €30 million to the BGV Fund IV by BioGeneration Ventures (BGV), a venture capital company supporting early-stage European biotech companies in health care. The EIF's commitment is made possible through a guarantee provided by the European Fund for Strategic Investments (EFSI), the main pillar of the Investment Plan for Europe. The BGV Fund IV, which has closed at €140m, has already made four investments with a focus on entrepreneurial therapeutic innovation, with more to come. Economy Commissioner Paolo Gentiloni said: “I warmly welcome the Investment Plan for Europe's support for this EIF investment in BGV. It will support this specialised fund to finance early-stage European biotech companies operating at the forefront of health-care innovation.” The Investment Plan for Europe has so far mobilized €535 billion of investment across the EU, a quarter of which for research, development and innovation projects. The press release is available here.
Share this article:
-
France4 days ago
France passes new anti-cult law against Senate’s opposition
-
Conferences4 days ago
National Conservatives vow to go ahead with Brussels event
-
Conferences1 day ago
NatCon’s on-off conference halted by Brussels police
-
NATO5 days ago
‘No violence or intimidation’ can block Ukraine’s NATO path